BlackRock Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$171K Sell
15,785
-391
-2% -$5.21K ﹤0.01% 2789
2016
Q3
$264K Sell
16,176
-44,657
-73% -$629K ﹤0.01% 2534
2016
Q2
$580K Sell
60,833
-6,975
-10% -$75.9K ﹤0.01% 2036
2016
Q1
$952K Buy
67,808
+954
+1% +$9.87K ﹤0.01% 1764
2015
Q4
$726K Buy
66,854
+2,536
+4% +$22.9K ﹤0.01% 1900
2015
Q3
$438K Sell
64,318
-4,883
-7% -$37.8K ﹤0.01% 2279
2015
Q2
$632K Buy
+69,201
New +$525K ﹤0.01% 2004
2014
Q3
Sell
-4,610
Closed -$19K 3734
2014
Q2
$19K Sell
4,610
-10,502
-69% -$55.6K ﹤0.01% 3465
2014
Q1
$120K Buy
15,112
+701
+5% +$5.22K ﹤0.01% 2943
2013
Q4
$102K Buy
14,411
+1,421
+11% +$9.47K ﹤0.01% 3037
2013
Q3
$96K Buy
12,990
+199
+2% +$1.55K ﹤0.01% 2985
2013
Q2
$111K Buy
+12,791
New +$82.2K ﹤0.01% 2830

Other funds holding NPTN

BlackRock Advisors's NPTN Position: Q4 2016 in Review

BlackRock Advisors reduced its NEOPHOTONICS CORP (NPTN) stake by 2.4% in Q4 2016, selling an estimated $5.21K and leaving 15,785 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

BlackRock Advisors first reported a position in NPTN in Q2 2013 and has held it in 12 quarters since. The position peaked at $952K in Q1 2016. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.

  • BlackRock Advisors held 15,785 shares of NEOPHOTONICS CORP worth $171K as of Q4 2016.
  • BlackRock Advisors sold 391 NEOPHOTONICS CORP shares in Q4 2016, an estimated $5.21K.
  • NEOPHOTONICS CORP made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2789 holding.
  • BlackRock Advisors first reported a position in NEOPHOTONICS CORP in Q2 2013 and has held it in 12 quarters since.
  • BlackRock Advisors's NEOPHOTONICS CORP position peaked at $952K in Q1 2016.
  • 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.